1. Academic Validation
  2. MIP-T3 associates with IL-13Ralpha1 and suppresses STAT6 activation in response to IL-13 stimulation

MIP-T3 associates with IL-13Ralpha1 and suppresses STAT6 activation in response to IL-13 stimulation

  • FEBS Lett. 2003 Aug 28;550(1-3):139-43. doi: 10.1016/s0014-5793(03)00860-3.
Yamei Niu 1 Takashi Murata Ken Watanabe Koji Kawakami Akihiko Yoshimura Jun-ichiro Inoue Raj K Puri Nobuyuki Kobayashi
Affiliations

Affiliation

  • 1 Division of Molecular Pharmacology of Infectious Agents, Graduate School of Biomedical Science, Nagasaki University, Nagasaki 852-8521, Japan.
Abstract

To unravel the mechanism of interleukin-13 (IL-13)-specific functions, we sought to identify IL-13 Receptor (IL-13R) binding molecules. A novel human IL-13Ralpha1 binding protein (IL13RBP1) has been identified using yeast tri-hybrid system, which was found to encode the same protein as MIP-T3 (microtubule interacting protein that associates with tumor necrosis factor (TNF) receptor associating factor-3 (TRAF3)). It constitutively associates with IL-13Ralpha1 and suppresses IL-4/13-induced signal transducer and activator of transcription-6 (STAT6) phosphorylation. IL-13-induced STAT6 activation was also inhibited as determined by dual luciferase assay and electrophoretic mobility shift assay (EMSA). These results suggest that MIP-T3 is a novel inhibitor of IL-13 signaling and may be a useful molecule in ameliorating various conditions in which IL-13 plays a central role.

Figures